Bayer’s head of Pharmaceuticals talks to Euractiv about US tariffs, expresses scepticism over CMA, and how the discussion on RDP should be focused on increasing it for incentivising competitiveness.
Where does the money collected from tariffs go? How soon will prices rise for consumers? What tariffs are other countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback